Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic profiling of normal plasma cells and MM models using bulk RNA-Seq

ABSTRACT: Transcriptomic profiling of normal plasma cells and MM models using bulk RNA-Seq

PROVIDER: PRJNA643511 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12125427.fastq.gz	Fastqsanger.gz
	SRR12125428.fastq.gz	Fastqsanger.gz
	SRR12125429.fastq.gz	Fastqsanger.gz
	SRR12125430.fastq.gz	Fastqsanger.gz
	SRR12125431.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 13

Similar Datasets

Transcriptomic profiling of normal plasma cells and MM models using bulk RNA-Seq

Project description:NRAS Q61 mutations are prevalent in advanced/relapsed multiple myeloma (MM) and correlate with poor patient outcomes. Thus, we generated a novel MM model by conditionally activating expression of endogenous NrasQ61R and a MYC transgene in germinal center B cells (VQ mice). VQ mice developed a highly malignant MM characterized by high proliferation index, hyperactivation of ERK and AKT signaling, impaired hematopoiesis, widespread extramedullary disease, bone lesions, kidney abnormalities, preserved PD1 and TIGIT immune checkpoint pathways, and expression of human high-risk MM gene signatures. VQ MM mice recapitulate most of the biological and clinical features of human advanced/high-risk MM. These MM phenotypes are serially transplantable in syngeneic recipients. Two MM cell lines were also derived to facilitate future genetic manipulations. Combination therapies based on MEK inhibition significantly prolonged the survival of VQ mice with advanced stage MM. Our study provides a strong rationale to develop MEK inhibition-based therapies for treating advanced/relapsed MM.

2020-07-02 | GSE153626 | GEO

MM in murine models: WES

Project description:MM in murine models: WES

| PRJEB18119 | ENA

RNA-Seq of transgenic plasma cells from the described subgroup-specific MM mouse models

Project description:RNA-Seq of transgenic plasma cells from the described subgroup-specific MM mouse models

| PRJNA759563 | ENA

Tumor cells in light-chain amyloidosis and multiple myeloma show different transcriptional rewiring of the normal plasma cell development [bulk RNA-seq]

Project description:Transcriptional atlas of normal PC development in secondary lymphoid organs (SLO), peripheral blood (PB) and BM for comparison with the transcriptional programs (TPs) of tumor PCs in AL, MM and MGUS based on bulk and single-cell RNAseq

2021-06-29 | GSE175384 | GEO

Human Plasma Proteome During Normal Pregnancy

Project description:Human Plasma Proteome During Normal Pregnancy

| PRJNA851013 | ENA

RNA-seq of peripheral blood mononuclear cell (PBMC) derived from normal healthy donors and multiple myeloma (MM) patients

Project description:Multiple myeloma (MM), also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. There is no cure for MM. In addition, the mechanism underlying abnormal production of plasma cells is not clear. In this experiment, peripheral blood was obtained from normal healthy donors and multiple myeloma (MM) patients. Peripheral blood mononuclear cells (PBMC) were separated by Ficoll separation solution. Samples of four donors were pooled and Samples of four MM patients were pooled. The aim was to characterize the mRNA profile of MM patients compared to healthy donors and find the new target of diagnosis or treatment for MM.

2020-08-14 | E-MTAB-7146 | biostudies-arrayexpress

Agilent SBC-ceRNA microarray chips were employed to detect the 3 normal plasma cells (NPCs), 5 lgD MM samples and 5 lgG MM samples respectively.

Project description:Agilent SBC-ceRNA microarray chips were employed to detect the 3 normal plasma cells (NPCs), 5 lgD MM samples and 5 lgG MM samples respectively.

| PRJNA730316 | ENA

Expression data from mouse Malignant Mesothelioma (MM) tumors and normal tissues

Project description:With the goal of designing a universal vaccine that can be used to target MM in mice, we analyzed expression of all the mRNA produced by different MM tumors and normal tissues. Our hypothesis was that antigens highly expressed in MM tumors can be used as target for vaccination, as long the expression of those antigens is extremely low in all normal mouse tissues.

2018-11-01 | GSE122004 | GEO

Agilent SBC-ceRNA microarray chips were employed to detect the 3 normal plasma cells (NPCs), 5 lgD MM samples and 5 lgG MM samples respectively.

Project description:We report the application of SBC-ceRNA microarray chips of diffenertially expressed circRNAs in IgD MM for high-throughput profiling of healthy controls, clinical IgG MM and IgD MM patients using SBC-ceRNA(homo 4*180K) chip.A total of 28,456 circRNAs were identified and 5939 were differentially expressed between IgD MM and IgG MM tissues

2022-03-15 | GSE174510 | GEO

Tumor cells in light-chain amyloidosis and multiple myeloma show different transcriptional rewiring of the normal plasma cell development [single-cell RNA-seq]

2021-06-29 | GSE175385 | GEO